US Stock MarketDetailed Quotes
ORGO Organogenesis
- 2.915
- +0.135+4.86%
Trading Nov 4 11:40 ET
386.46MMarket Cap-24291P/E (TTM)
2.930High2.750Low43.18KVolume2.780Open2.780Pre Close123.76KTurnover0.07%Turnover Ratio72.88P/E (Static)132.58MShares4.70552wk High1.47P/B174.20MFloat Cap2.11552wk Low--Dividend TTM59.76MShs Float310.900Historical High--Div YieldTTM6.48%Amplitude1.795Historical Low2.866Avg Price1Lot Size
Organogenesis Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -45.20%4.74M | -100.16%-10.16M | 24.37%30.92M | 36.06%10.61M | 206.90%16.74M | -15.19%8.65M | -459.82%-5.08M | -59.89%24.86M | -56.54%7.8M | -80.42%5.45M |
| Net income from continuing operations | -420.60%-17.04M | 29.27%-2.1M | -68.16%4.95M | -107.59%-568K | 1,372.56%3.17M | -39.20%5.32M | -225.19%-2.97M | -83.51%15.53M | -85.32%7.49M | -98.29%215K |
| Operating gains losses | 14.93%2.25M | 27.37%2.55M | -94.76%235K | -7.76%-5.83M | -65.12%2.11M | -2.10%1.96M | 8.39%2M | 36.23%4.48M | -54,230.00%-5.41M | 98.95%6.05M |
| Depreciation and amortization | 21.49%4.2M | 1.25%3.97M | 30.05%23.45M | 22.47%12.29M | 41.03%3.77M | 25.75%3.46M | 52.80%3.92M | 8.13%18.03M | 108.13%10.04M | -43.45%2.68M |
| Deferred tax | ---- | ---- | 1.62%2.01M | ---- | ---- | ---- | ---- | 106.19%1.98M | ---- | ---- |
| Other non cash items | -6.08%2.15M | 67.60%2.74M | -23.88%8.06M | 36.64%3.02M | -57.75%1.12M | -30.07%2.29M | -33.60%1.64M | 6.54%10.58M | -48.72%2.21M | -6.68%2.64M |
| Change In working capital | -14.25%-7.56M | -75.04%-20.7M | 46.97%-18.07M | 76.49%-2.65M | 135.31%3.02M | 20.68%-6.62M | -100.53%-11.83M | 7.91%-34.08M | 5.41%-11.28M | -410.22%-8.56M |
| -Change in receivables | -604.80%-10.86M | -340.86%-15.12M | 163.16%5.54M | 166.42%7.3M | 163.86%3.21M | 83.65%-1.54M | -216.55%-3.43M | 69.39%-8.77M | 132.21%2.74M | -482.71%-5.03M |
| -Change in inventory | 241.39%2.66M | -115.90%-4.67M | 13.08%-8.18M | 66.82%-706K | 10.75%-3.43M | 46.55%-1.88M | -2,803.75%-2.16M | -1.16%-9.41M | -584.74%-2.13M | 19.26%-3.84M |
| -Change in prepaid assets | 104.16%3.88M | 9.61%-4.32M | -2,575.93%-10.12M | -1,383.91%-5.62M | -187.88%-1.62M | 482.82%1.9M | -120.51%-4.77M | -1,011.76%-378K | -692.19%-379K | 18.63%1.84M |
| -Change in payables and accrued expense | 114.40%444K | 771.83%5.57M | 135.27%3.03M | 84.80%-1.49M | 2,980.53%6.96M | -151.49%-3.08M | 112.74%639K | -165.07%-8.59M | -916.51%-9.79M | -97.38%226K |
| -Change in other current liabilities | -42.22%26K | 27.27%28K | 26.39%91K | -30.30%23K | -93.75%1K | 246.15%45K | 120.00%22K | 101.19%72K | 101.05%33K | 100.62%16K |
| -Change in other working capital | -80.40%-3.71M | -3.63%-2.2M | -20.45%-8.44M | -22.84%-2.16M | -18.34%-2.1M | -19.47%-2.06M | -21.19%-2.12M | -13.81%-7.01M | 11.18%-1.76M | -26.55%-1.78M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -45.20%4.74M | -100.16%-10.16M | 24.37%30.92M | 36.06%10.61M | 206.90%16.74M | -15.19%8.65M | -459.82%-5.08M | -59.89%24.86M | -56.54%7.8M | -80.42%5.45M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 74.93%-1.88M | 70.62%-2.22M | 28.13%-24.36M | 68.81%-3.32M | 42.52%-5.98M | -21.58%-7.5M | -13.34%-7.56M | -8.58%-33.9M | -103.86%-10.66M | 37.72%-10.4M |
| Net PPE purchase and sale | 74.93%-1.88M | 70.62%-2.22M | 28.13%-24.36M | 68.81%-3.32M | 42.52%-5.98M | -21.58%-7.5M | -13.34%-7.56M | -8.58%-33.9M | -103.86%-10.66M | 37.72%-10.4M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 74.93%-1.88M | 70.62%-2.22M | 28.13%-24.36M | 68.81%-3.32M | 42.52%-5.98M | -21.58%-7.5M | -13.34%-7.56M | -8.58%-33.9M | -103.86%-10.66M | 37.72%-10.4M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -63.85%-1.73M | -111.00%-2.61M | -150.34%-5.51M | 5.23%-1.78M | -5,630.77%-1.44M | -353.98%-1.05M | -61.57%-1.24M | -112.26%-2.2M | -104.47%-1.88M | -97.95%26K |
| Net issuance payments of debt | -64.02%-1.67M | -77.83%-1.67M | -71.69%-5.17M | 5.17%-1.78M | ---1.44M | -78.95%-1.02M | -65.14%-938K | -49.60%-3.01M | -87.50%-1.88M | --0 |
| Proceeds from stock option exercised by employees | --0 | --180K | --0 | --0 | --0 | --0 | --0 | -5.82%2.07M | --0 | -96.92%28K |
| Net other financing activities | -58.82%-54K | -275.84%-1.12M | 73.57%-332K | --1K | 50.00%-1K | 95.56%-34K | 38.93%-298K | -2.95%-1.26M | --0 | ---2K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -63.85%-1.73M | -111.00%-2.61M | -150.34%-5.51M | 5.23%-1.78M | -5,630.77%-1.44M | -353.98%-1.05M | -61.57%-1.24M | -112.26%-2.2M | -104.47%-1.88M | -97.95%26K |
| Net cash flow | ||||||||||
| Beginning cash position | -0.08%89.35M | 1.01%104.34M | -9.81%103.29M | -8.51%98.83M | -20.75%89.51M | -17.59%89.42M | -9.81%103.29M | 35.05%114.53M | 5.16%108.02M | 25.07%112.94M |
| Current changes in cash | 1,116.13%1.13M | -8.05%-14.99M | 109.33%1.05M | 216.53%5.51M | 289.25%9.32M | -97.91%93K | -130.25%-13.88M | -137.81%-11.24M | -140.08%-4.73M | -139.65%-4.92M |
| End cash Position | 1.08%90.48M | -0.08%89.35M | 1.01%104.34M | 1.01%104.34M | -8.51%98.83M | -20.75%89.51M | -17.59%89.42M | -9.81%103.29M | -9.81%103.29M | 5.16%108.02M |
| Free cash flow | 149.17%2.86M | 2.02%-12.38M | 172.50%6.55M | 355.22%7.29M | 317.34%10.76M | -71.52%1.15M | -140.24%-12.64M | -129.39%-9.04M | -122.45%-2.86M | -144.40%-4.95M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data